Hims & Hers Health Shares Plunge After Price Target Cut to $20
TD Cowen cut Hims & Hers Health's price target from $30 to $20 and maintained a hold rating on the stock. Shares gapped down, opening at $17.83 after a prior close of $23.02.
1. Analyst Downgrade
TD Cowen lowered its price target on Hims & Hers Health by 33%, moving it from $30 to $20 and kept a hold rating, signaling tempered confidence in near-term growth prospects.
2. Market Reaction
Following the downgrade, shares of Hims & Hers Health opened at $17.83 on Monday, representing a 22.6% gap down from Friday’s closing price of $23.02 as investors adjusted to the revised outlook.
Related News
GOOG
OpenAI Eyes Fall IPO After Lawsuit Win, Battling $900B Anthropic Rival
GOOG•
IPW
iPower Cuts Q3 Costs 66%, Narrows Loss to $0.3M, Secures $2.6M Sublease
IPW•
NVDA
Nvidia posts US$81.6B Q1 revenue, forecasts US$91B for Q2
NVDA•
SVM
Silvercorp Secures 30-Year License Extension, Pays $60M for Tulkubash/Kyzyltash JV
SVM•
HOOD
Robinhood Secures $3B Wells Fargo TradePMR Team, CFO to Present May 27
HOOD•
Sources
FD